The evidence base includes the STEP program for semaglutide (NEJM, 2021) and the SURMOUNT program for tirzepatide (NEJM, 2022), with SURMOUNT-OSA extending tirzepatide study into obstructive sleep apnea (NEJM, 2024)
doi: 10.33607/bjshs.v1i104.9
We've seen clients add 500ml of water intake per day and report noticeable improvements in subjective energy within 72 hours
The above studies show that GLP-1 and GLP-1RAs can enhance BAT function or promote WAT browning through the center
Tirzepatide is a medication used for managing type 2 diabetes and, in some cases, for weight loss
Future research will be critical in shaping how health professionals support patients to make confident, informed choices about their long term options